Novo Nordisk’s once-daily GLP-1 tablet reduced major adverse cardiovascular events in high-risk adults, including those without prior heart attack or stroke.
Health care drives the year’s employment growth—yet limits on immigrant labor and looming Medicaid reductions could sap momentum and leave hospitals and home care struggling to hire.